Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes – a cross-sectional study

References

• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13.
   PubMed Web of Science ®Google Scholar
• Pellatt L, Rice S, Mason HD. Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139:825–833.
   PubMed Web of Science ®Google Scholar
• Tian X, Ruan X, Mueck AO, Wang J, Liu S. Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China. Gynecol Endocrinol. 2014;30:126–129.
   PubMed Web of Science ®Google Scholar
• Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296:E238–243.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981–1030.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Sova H, Unkila-Kallio L, Tiitinen A, et al. Hormone profiling, including anti-müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecol Endocrinol. 2019:1–6.
   PubMed Web of Science ®Google Scholar
• Amini P, Omani-Samani R, Hosseini R, Ahmadi J, Maroufizadeh S. A cross-sectional comparison of clinical and endocrine parameters among phenotypes of polycystic ovarian syndrome in Iranian population. Middle East Fertil Soc J. 2018;23:425–430.
   Web of Science ®Google Scholar
• Sahmay S, Aydogan Mathyk B, Sofiyeva N, Atakul N, Azemi A, Erel T. Serum AMH levels and insulin resistance in women with PCOS. Eur J Obstet Gynecol Reprod Biol. 2018;224:159–164.
   PubMed Web of Science ®Google Scholar
• Wiweko B, Indra I, Susanto C, Natadisastra M, Hestiantoro A. The correlation between serum AMH and HOMA-IR among PCOS phenotypes. BMC Res Notes. 2018;11:114.
   PubMedGoogle Scholar
• Fauser BCJM, Tarlatzis BC, Rebar RW, Legro R, Balen A, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97:28–38.e25.
   PubMed Web of Science ®Google Scholar
• Baldani DP, Skrgatić L, Simunić V, Zlopasa G, Canić T, Trgovcić I. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population. Coll Antropol. 2013;37:477–482.
   PubMedGoogle Scholar
• Chen M-J, Yang W-S, Chen C-L, Wu M-Y, Yang Y-S, Ho H-N. The relationship between anti-mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod. 2008;23:952–957.
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014;12:89.
   PubMed Web of Science ®Google Scholar
• Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24:2917–2923.
   PubMed Web of Science ®Google Scholar
• Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G et al. Is the plasma anti-müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol. 2011;158:254–259.
   PubMed Web of Science ®Google Scholar
• Carlsen SM, Vanky E, Fleming R. Anti-müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod. 2009;24:1732–1738.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG. 2009;116:1633–1639.
   PubMed Web of Science ®Google Scholar
• Tian X, Ruan X, Mueck AO, Wallwiener D, Wang J, Liu S et al. Serum anti-müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China. Gynecol Endocrinol. 2014;30:836–839.
   PubMed Web of Science ®Google Scholar
• Nelson SM, La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod Biomed Online. 2011;23:411–420.
   PubMed Web of Science ®Google Scholar
• Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47.
   PubMed Web of Science ®Google Scholar
• Fonseca HP, Brondi RS, Piovesan FX, Miklos TG, Aldrighi JM. Anti-mullerian hormone and insulin resistance in polycystic ovary syndrome. Gynecol Endocrinol. 2014;30:667–670.
   PubMed Web of Science ®Google Scholar
• Caglar GS, Kahyaoglu I, Pabuccu R, Demirtas C, Seker R. Anti-mullerian hormone and insulin resistance in classic phenotype lean PCOS. Arch Gynecol Obstet. 2013;288:905–910.
   PubMed Web of Science ®Google Scholar